Fundraising Fox

Kalobios Pharmaceuticals

South San Francisco, US · Delaware corporation

Biotech

Founders & leadership

Board

DM
David MoradiBoard director
MH
Michael HarrisonBoard director

Reported raises · per SEC filings

Form D private placements

$22.2M disclosed across 5 rounds · 2015–2019

▶$494.6KraisedNov 2019 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Cameron DurrantExecutive Officer, Director
  • Ronald BarliantDirector
  • Rainer BoehmDirector
  • Robert SavageDirector
  • Timothy MorrisDirector
Offering amount
$20.5M
Amount sold
$494.6K
First sale
Nov 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedMay 2019 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Greg JesterExecutive Officer
  • Rainer BoehmDirector
  • Robert SavageDirector
  • Timothy MorrisDirector
  • Ronald BarliantDirector
  • Cameron DurrantExecutive Officer, Director
Offering amount
$5M
Amount sold
$1.3M
First sale
Apr 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15KraisedSep 2017 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Greg JesterExecutive Officer
  • Ezra FriedbergDirector
  • Timothy MorrisDirector
  • Ronald BarliantDirector
  • Dale ChappellDirector
  • Morgan LamExecutive Officer
  • Cameron DurrantExecutive Officer, Director
Offering amount
$15M
Amount sold
$15K
First sale
Aug 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.2MraisedJul 2016 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Morgan LamExecutive Officer
  • Dale ChappellDirector
  • Dean Witter IIIExecutive Officer
  • Timothy MorrisDirector
  • Ezra FriedbergDirector
  • Cameron DurrantExecutive Officer, Director
  • Ronald BarliantDirector
Offering amount
$12.2M
Amount sold
$12.2M
First sale
Jun 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.2MraisedJan 2016 · 18 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David MoradiDirector
  • Michael HarrisonDirector
Offering amount
$8.8M
Amount sold
$8.2M
First sale
Dec 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Kalobios Pharmaceuticals raised?
Kalobios Pharmaceuticals has disclosed $22.2M raised across 5 rounds.
Where is Kalobios Pharmaceuticals headquartered?
Kalobios Pharmaceuticals is headquartered in South San Francisco, US.